Skip to main content
Premium Trial:

Request an Annual Quote

GTC Wins Biogen Contract, Hits Schering Milestone

Premium

WALTHAM, Mass.--Genome Therapeutics has begun work on a sequencing contract for Biogen. Genome Therapeutics will employ its proprietary sequencing techniques, automation, bioinformatics, and quality control procedures to generate desired sequence reads and provide analysis of sequenced regions for Biogen.

Separately, the company announced that it has reached another milestone in its genomics research alliance with Schering-Plough by delivering assays for multiple targets related to two medically important fungal pathogens, Candida albicans and Aspergillus fumigatus. The milestone triggered a payment to Genome Therapeutics.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.